Strain variation in parainfluenza virus type 4
Hiroshi Komada, ~*,3 Ivar Orstavik, 2 Yasuhiko lto 3 and Erling Norrby ~ 1Department of Virology, Karolinska Institute, School of Medicine, Stockholm, Sweden, 2Division of Virology, National Institute of Public Health, Oslo, Norway and 3Department of Microbiology, Mie University School of Medicine, Tsu, Mie, Japan Variations in epitopes on structural proteins of four isolates of parainfluenza virus type 4 (PIV-4) and the Mr ofpolypeptides in these isolates were determined by radioimmune precipitation assay with monoclonal antibodies to parainfluenza virus type 4A (PIV-4A) and type 4B (PIV-4B). Three isolates antigenically resembled the prototype PIV-4A and the sizes of their structural proteins were 72K (HN protein), 61K (Fo protein), 61K (NP protein) and 40K (M protein). However, one virus isolate showed marked antigenic differences from both the 4A and 4B prototype viruses, particularly with regard to properties of the HN and F proteins. In addition, both the NP and Fo proteins of this isolate had a slightly increased Mr of 63K.
Human parainfluenza virus type 4 (PIV-4), which belongs to the family Paramyxoviridae, is an important respiratory tract pathogen in infants and children. PIV-4 was first isolated and characterized by Johnson et al. (1960) . Subsequently, antigenic heterogeneity in PIV-4 has been observed by use of polyclonal antisera in haemadsorption inhibition tests with different strains of PIV-4 (Chanchola et al., 1964) . This finding led to a subdivision of PIV-4 into two serotypes, 4A and 4B. Recently we have generated monoclonal antibodies (MAbs) to PIV-4A and PIV-4B and identified their structural proteins (Komada et al., 1989a, b) . The PIV-4A HN, F0, NP and M proteins are 72K, 61K, 61K and 40K, respectively; PIV-4B HN, F0, NP and M proteins are 72K, 65K, 65K and 40K, respectively. There are characteristic NP and F 0 protein size differences between the two subtypes. Intratypic and intertypic immunological relationships among four PIV-4A isolates and four PIV-4B isolates in Japan were investigated by ELISA employing MAbs (Komada et al., 1989b) . It was found that whereas virus surface glycoproteins were well conserved among homologous virus types, pronounced differences, especially in the HN protein, were seen between the two types. In the present investigation, we analysed the epitopic variations among four isolates of PIV-4 on the size of structural polypeptides of these isolates by radioimmune precipitation assay (RIPA) using previously defined PIV-4 specific MAbs. One of the four isolates showed unique characteristics.
LLC-MK2 and primary monkey kidney (PMK) cells were grown in Eagle's minimum essential medium (MEM) supplemented with 5~ foetal calf serum. The Toshiba (M-25) strain of PIV-4A (Denka Institute of Biological Science, Japan) and 68-333 strain of PIV-4B (a kind gift from Dr F. Nishikawa, National Institute of Health, Japan) were used as prototype viruses. Four field isolations of PIV-4 were made at the National Institute of Public Health in Oslo, Norway, between 1986 and 1989. The viruses were grown in LLC-MKe cells cultured in serum-free MEM containing 2 ~tg/ml of trypsin. Isotopic labelling of the viruses was carried out using PMK cells according to the method described previously (Ito et al., 1985 (Ito et al., , 1987 . Approximately 2 × 106 cells were infected with virus at an input m.o.i, of 0.01 TCID50 per cell. One and a half h after inoculation, the cells were depleted of methionine and labelled with [3SS]methionine (100 ~tCi in 300 ~tl of culture medium) for 3 days. The cultures were washed once with phosphate-buffered saline (PBS) pH 7.2 and lysed with 500 ~tl of RIPA buffer (150 mM-NaC1, 1~ sodium deoxycholate, 1~ Triton X-100, 0.1~ o SDS, 10 m~-Tris-HC1 pH 7-4 and 1 mM-phenylmethylsulphonylfluoride). RIPA and SDS-PAGE were performed as described previously (Ito et al., 1985 (Ito et al., , 1987 . Five ~tl of mouse ascites fluid was incubated with 50 txl of Protein A-Sepharose (Pharmacia) at 4 °C overnight, and after two washes with PBS, the mixture was further incubated with [35S]methionine-labelled virus-infected cell extract (20 ktl) at room temperature for 2 h. After washing five times with RIPA buffer and once with PBS, the samples were fractionated by SDS-PAGE (Laemmli, 1970) . Forty-nine MAbs to PIV-4A components and 30 MAbs to PIV-4B components (Komada et al., 1989b) were used to analyse the epitopic variation of the four field isolates and anti-HN MAbs (PIV-4A-0000-9334 © 1990 SGM The PIV-4A-specific MAb A125 and the PIV-4B-specific MAb Bll were used in lanes 1 to 5 and lanes 6 to 10, respectively. The antigens used were the homotype prototype in lanes 1 and 6, strain 1 in lanes 2 and 7, strain 2 in lines 3 and 8, strain 3 in lanes 4 and 9 and strain 4 in lanes 5 and 10. Note the deviating size characteristics of strain 3. Lane m shows Mr markers; * indicates cellular actin.
specific, A138, A156 and A158; PIV-4B-specific, B23 and B32), anti-F MAbs (PIV-4A-specific, A133; PIV-4B-specific, B02), anti-NP MAbs (PIV-4A-specific, A125; PIV-4B-specific, B l 1) and anti-M MAb (PIV-4A-specific, A046) were used to identify the polypeptides of the four isolates. In the analysis of epitopic variation among the isolates, it was found that all PIV-4A-specific anti-HN MAbs reacted strongly with isolates 1, 2 and 4, but that only two MAbs (A156 and A158) showed a weak reaction with isolate 3 (Table 1) . PIV-4B-specific MAbs showed very limited reactions with the four isolates (Table 1) . Of six MAbs to PIV-4A F protein, five reacted strongly with isolates 1, 2 and 4, whereas only one MAb reacted with isolate 3 (data not shown). Of 10 MAbs to PIV-4B F protein, four reacted with isolates 1 and 2, and five reacted with isolate 4, whereas only one MAb reacted with isolate 3 (data not shown). These results suggested that isolates 1, 2 and 4 belong to type 4A. Both NP and M proteins were well conserved among all the four isolates (data not shown). Because of the poor growth capacity of the isolates, it was not possible to confirm data obtained in RIPAs by ELISA. The sizes of polypeptides of the isolates were determined by the use of MAbs. The Mr of the HN protein of the four isolates was 72K (data not shown) and that of the M protein of the four isolates was 40K (data Table 1 .
Reactivity of PIV-4A and PIV-4B anti-HN MAbs in tests with four Norwegian isolates of PIV-4
Anti-HN MAb* PIV-4 Previously studied isolate Japanese PIV-4 isolates Type MAb specificity designation Group 1 2 3 4 PIV-4A (4)t PIV-4B (4) * The properties of these MAbs were described in Komada et al. (1989b) .
Number of isolates given in parenthesis (see Komada et al., 1989b) . Number of positive reactions determined by ELISA in a previous study (Komada et al. 1989b) .
§ w, Weak reaction.
not shown). These sizes agree with those determined for the homologous proteins of prototype PIV-4A and PIV-4B (Komada et al., 1989a, b) . However, there were slight but distinct differences in the Mr of the NP protein of the four isolates. The Mr of the NP protein of prototype PIV-4A and -4B was previously shown to be 61K and 65K, respectively (Komada et al., 1989a, b) . The Mr of the NP protein of isolates 1, 2 and 4 were 61K, but that of isolate 3 was somewhat higher, 63K (Fig. 1) .
The same results were obtained in tests with specific polyclonal antisera to PIV-4A and PIV-4B (data not shown). The Mr of the F 0 protein of prototypes PIV-4A and PIV-4B were previously shown to be 61K and 65K respectively (Komada et al. 1989a, b) and again the size of this protein of isolates 1, 2 and 4 was 61K as for type PIV-4A, but that of isolate 3 was slightly higher, 63K (data not shown). Taken together, these data strongly suggest that isolates 1, 2 and 4 represent PIV type 4A, but that isolate 3 does not seem to fit with either type 4A or type 4B virus. Our analyses with a large colTection of PIV-4-specific MAbs allowed us to examine the cross-reactivity between prototype viruses and four isolates as well as to determine the size of the polypeptides of these isolates. The isolates were originally identified by the use of immunofluorescence using PIV-4A-specific polyclonal antiserum supplied by Dr P. Gardner (Newcastle, U.K.). The use of this reagent did not indicate whether the four isolates would be expected to represent type 4A or type 4B virus. Although PIV-4A and PIV-4B types can be distinguished by polyclonal antisera in haemadsorption inhibition tests (Canchola et aL, 1964) , they also express pronounced cross-reactivity to each other (Komada et al., 1989b) , and type 4B virus can be detected by using PIV-4A-specific polyclonal antisera and vice versa (H. Komada et al., unpublished data) .
The striking finding of this study is that isolate 3 does not seem to behave either like PIV-4A or like PIV-4B. Attempts have been made to produce polyclonal antisera to isolate 3 in order to carry out cross-neutralization tests. However so far these attempts have been unsuccessful because of the poor growth of the virus, which has precluded the accumulation of sufficient antigens for immunization. Up to now, only limited studies of PIV-4 had been undertaken. Previously the antigenic diversities were examined and the polypeptides were identified for a small number of strains (Komada et al., 1989a, b) . The present findings of a potential new type of PIV-4 warrant further studies of the immunogenic and eventually the genetic diversity of PIV-4 viruses. There is a further need to correlate the emerging knowledge about the properties of the virus with viral epidemiology and pathogenesis.
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